System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Ahead of print 1 citation

PubMed: 42469198 DOI: 10.1038/s41398-026-04274-1

Biological correlates of cancer-related fatigue in older male cancer survivors.

Transl Psychiatry

Authors: Samuel Tundealao, Michael R Irwin, Steve Cole, Cindy K Blair, Shou-En Lu, Biren Saraiya, Isaac Y Kim, Dolores D Guest, Yong Lin, Jinghua An, Evelyn Arana-Chicas, Chunxia Chen, Elizabeth Handorf, Antoinette Stroup, Yibin Kang, Wadih Arap, Anita Y Kinney

Affiliations

  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA.
  • Rutgers Cancer Institute, New Brunswick, NJ, USA.
  • Department of Psychiatry, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Cousins Center for Psychoneuroimmunology, Semel Institute for Neurosciences, University of California-Los Angeles, Los Angeles, CA, USA.
  • University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
  • Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Division of Medical Oncology, Section of Solid Tumors, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
  • Yale New Haven Hospital, New Haven, CT, USA.
  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA. Rutgers Cancer Institute, New Brunswick, NJ, USA.
  • Indiana University School of Nursing, Indianapolis, IN, USA.
  • Division of Medical Oncology, Section of Behavioral Science, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
  • Department of Molecular Biology and Ludwig Institute for Cancer Research-Princeton Branch, Princeton University, Princeton, NJ, USA.
  • Rutgers Cancer Institute, Newark, NJ, USA.
  • Division of Hematology and Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA.
  • Rutgers Cancer Institute, New Brunswick, NJ, USA.

Abstract

Older male cancer survivors often experience chronic fatigue. Although the pathogenesis of cancer-related fatigue (CRF) remains unclear, circulating inflammatory markers and gene expression profiles may provide insights into the underlying biological mechanisms of persistent CRF. We examined the potential biological correlates of CRF in older male cancer survivors. This is a secondary analysis of baseline data from a randomized controlled trial that examined the effects of Tai Chi Qigong on fatigue and inflammation biology among 107 older male cancer survivors (≥ 55 years). Fatigue was assessed with the Functional Assessment of Chronic Illness-Fatigue Scale. Blood samples were collected for circulating inflammatory biomarkers (C-reactive protein, IL-6, IL-8, IL-10, IFN-γ, TNF-α), and for genome-wide transcriptional profiling. Pearson's correlation and multivariable linear regression were used to assess these relationships while adjusting for sociodemographic and clinical factors. Due to multiple testing, false discovery rate-corrected p-values were reported. Worse fatigue was significantly associated with higher levels of CRP (p = 0.011), IL-6 (p = 0.002), and TNF-α (p = 0.010). Fatigue was also significantly correlated with increased expression of three immune-related genes, namely [CXCR4 (p = 0.023), IRF-7 (p = 0.009), and TGM2 (p = 0.018)], one mitochondrial-related gene [HSPA2 (p = 0.001)], one transcription factor gene [ETS1 (p = 0.037)], one neuropeptide [OPRL1 (0.036)], and decreased expression of two immune-related genes [LY6E (p = 0.029), COMMD9 (p = 0.034)], and three RNA/DNA processing genes [SNORD89 (p < 0.001), TFIP11 (p = 0.017), and UNG (p = 0.003)]. CRF was associated with inflammatory profiles and coordinated transcriptional shifts involving immune activation, neuro-immune signaling, mitochondrial dysfunction, and impaired nucleic acid processing, thereby offering a coherent biological context for CRF in this population. Clinical Trial Registration: The HERO Trial was registered in the NIH Clinical Trials Registry on November 17, 2017 (NCT03345563).

MeSH

Genes, Cancer Survivors, Neoplasms, Fatigue, Psychiatry